Resources

I-MAK’s team has spent the last decade increasing transparency on patents, innovation, and access.

FDA Submission for Administering The Hatch-Waxman Amendments: Ensuring A Balance Between Innovation And Access

“Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access” was a meeting held on July 18, 2017 to provide the public an opportunity to submit comments concerning administration of the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act (FD&C Act) to help ensure the intended balance between encouraging innovation in drug…

Commentaries 17 Sep 2017

Join us to stay updated
and help make lifesaving medicines accessible to all